Overview
Legal name
PLEXAA LTD
Region
Unknown
Registered address
20-22 WENLOCK ROAD
LONDON
ENGLAND
N1 7GU
Insolvency history
No
Company
Active
LTD
Company profile
Plexaa Ltd
BLOOM
Plexaa Ltd is a UK company with status active founded in 2019.
CRN
11798195
Founded
2019
Age
7
Latest accounts
Financial period: 1 Jan 2024 to 31 Dec 2024
FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
7
Company events
Reference milestones and recent Companies House filing stream events.
6 events
05 Feb
2027
Confirmation statement due
Confirmation DueNext confirmation statement due date
30 Sep
2026
Accounts due
Accounts DueNext accounts due date
22 Jan
2026
Confirmation statement filed
ConfirmationLast confirmation statement made up date
31 Dec
2024
Accounts filed
AccountsLast accounts made up date
25 Nov
2024
Accounts With Accounts Type Total Exemption Full
Accounts AnalysedAA | Transaction MzQ0NDc0ODkwNGFkaXF6a2N4
Published 25 Nov 2024 10:31
30 Jan
2019
Incorporated
InceptionCompany registered at Companies House
Public funding
2 awards
First funded
2023
Funded years
2023, 2024
Age at first award
4 years
Projects
2024
Collaborative R&D
Lead participant
The development of an app to support the pre-operative preparation of breast cancer patients and improve outcomes
1 May 2024 to 30 Apr 2025
Awarded
£99,954
Total cost £99,954
The NHS conducts \>10 million operations every year (HES, 2022). Approximately 20% of patients suffer significant postoperative complications (Ludbrook, 2022). Breast surgery represents one such example with a relatively high volume of procedures (102,000 per year in the NHS, England - GIRFT, 2021) and complication rates of up to 30% (Bennett 2018). This ...
2023
Collaborative R&D
Lead participant
Plexaa: an innovation in preoperative preconditioning for breast cancer surgery patients to prevent wound healing complications and improve outcomes
1 May 2023 to 31 Jan 2024
Awarded
£295,298
Total cost £421,855
The NHS conducts \>10m operations p.a (Hospital\_Episodes\_statistics). From these, roughly 20% of patients suffer significant postoperative complications (Nepogodiev-2019; International\_Surgical\_Outcomes Study Group-2016). As well as being potentially avoidable, stressful events, these complications extend hospital stays, clog up NHS beds and push up t...
Product types
Collaborative R&D